Results 171 to 180 of about 43,533 (201)
Some of the next articles are maybe not open access.
Current Opinion in Ophthalmology, 2014
Diabetic macular edema (DME) is one of the most common causes of visual loss in patients with diabetes mellitus. Many patients continue to lose vision despite laser photocoagulation and medical therapies. The two major categories of medications currently used to treat DME are corticosteroids and anti-VEGF agents.
Fabio, Patelli +2 more
+6 more sources
Diabetic macular edema (DME) is one of the most common causes of visual loss in patients with diabetes mellitus. Many patients continue to lose vision despite laser photocoagulation and medical therapies. The two major categories of medications currently used to treat DME are corticosteroids and anti-VEGF agents.
Fabio, Patelli +2 more
+6 more sources
International Ophthalmology Clinics, 1976
Photocoagulation by either the argon laser or xenon arc instruments has been reported to have a beneficial effect in selected patients with macular edema. Treatment is not effective in all cases; indeed, in some patients with perifoveal capillary closure, severe macular edema, long-standing organized hard exudates, or significant cystoid maculopathy ...
A, Patz, S L, Fine
openaire +2 more sources
Photocoagulation by either the argon laser or xenon arc instruments has been reported to have a beneficial effect in selected patients with macular edema. Treatment is not effective in all cases; indeed, in some patients with perifoveal capillary closure, severe macular edema, long-standing organized hard exudates, or significant cystoid maculopathy ...
A, Patz, S L, Fine
openaire +2 more sources
Acta Ophthalmologica, 2022
AbstractThe main diabetic macular edema (DME) treatment options include intravitreal injections of anti‐VEGF agents and intravitreal injections of corticosteroids. In the past, macular laser photocoagulation (LP) was a standard of DME treatment, however, now it is utilized as an additional treatment. Two most important techniques of LP in patients with
openaire +2 more sources
AbstractThe main diabetic macular edema (DME) treatment options include intravitreal injections of anti‐VEGF agents and intravitreal injections of corticosteroids. In the past, macular laser photocoagulation (LP) was a standard of DME treatment, however, now it is utilized as an additional treatment. Two most important techniques of LP in patients with
openaire +2 more sources
European Journal of Ophthalmology, 1998
Retinal edema is defined as any increase of water in retinal tissue resulting in an increase in its volume. This increase may be initially intracellular or extracellular. In the first case, there is cytotoxic edema. In the second, vasogenic edema, directly associated with an alteration of the blood-retinal barrier (BRB).
openaire +3 more sources
Retinal edema is defined as any increase of water in retinal tissue resulting in an increase in its volume. This increase may be initially intracellular or extracellular. In the first case, there is cytotoxic edema. In the second, vasogenic edema, directly associated with an alteration of the blood-retinal barrier (BRB).
openaire +3 more sources
2002
Diabetic retinopathy remains one of the four major causes of blindness in the western world [1], [2]. Blindness from diabetic retinopathy results from consequences of proliferative diabetic retinopathy and from diabetic macular edema. Proliferative diabetic retinopathy is more likely than macular edema to cause rapid and severe loss of vision.
openaire +1 more source
Diabetic retinopathy remains one of the four major causes of blindness in the western world [1], [2]. Blindness from diabetic retinopathy results from consequences of proliferative diabetic retinopathy and from diabetic macular edema. Proliferative diabetic retinopathy is more likely than macular edema to cause rapid and severe loss of vision.
openaire +1 more source
Integrative oncology: Addressing the global challenges of cancer prevention and treatment
Ca-A Cancer Journal for Clinicians, 2022Jun J Mao,, Msce +2 more
exaly

